Search results for: 'Global Precision Oncology Market Trends and Growth Opportunities'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metabolic disease, rare disorders, neuropsychiatry, and ne...

This edition of Trend Opportunity Profiles features trend advancements in Social and economic dimensions. The study examines the following trends: • Reskilling, • Food security • Revenge tourism • The “permacrisis” shaping consumer demand • The shifting social status of women • Content creator marketplaces • The pensioner boom Trend O...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...

Cities are proactively moving away from personal cars to other sustainable modes of transport. Shared electric modes of transport are likely to see an uptake, working in conjunction with traditional transport systems. Car-free cities, access regulations, and zero-emission deadlines will play a major role in shaping the carsharing industry. Carshari...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...

Precision medicine is transitioning toward wider acceptance, due to mounting payer pressures and regulatory changes that are shifting pharma businesses from prescriptive to more predictive and personalized models. Emergence of value-based reimbursement models and healthcare consumerism trends are helping move the treatment model from ‘one-size-fits...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

Prolonged geopolitical uncertainty, elevated energy costs, and persistent supply chain and trade disruptions define global economic conditions in Q3 2026. The US-Iran conflict has materially weakened the global growth trajectory, shaving 0.6 percentage points from the 2026 outlook (vs 3.5% in 2025) and slowing global GDP growth to 2.5% in Q3 2026, ...